China has approved CSPC Pharma’s RSV vaccine for clinical trials
China’s National Drug Administration has issued a release authorization to pharmaceutical group CSPC The drugmaker said it will begin clinical trials of a respiratory syncytial virus (RSV) vaccine in humans.
ПОПУЛЯРНЫЕ ПОСТЫ
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ
